PA
Perceptive Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.7M | Buy |
7,902,365
+28,017
| +0.4% | +$180K | 1.88% | 13 |
|
|
2025
Q1 | $27.9M | Buy |
7,874,348
+1,100,000
| +16% | +$3.89M | 0.98% | 28 |
|
|
2024
Q4 | $25.6M | Buy |
6,774,348
+4,648,699
| +219% | +$17.6M | 0.71% | 36 |
|
|
2024
Q3 | $6.89M | Buy |
+2,125,649
| New | +$6.89M | 0.15% | 75 |
|
|
2024
Q2 | – | Sell |
-300,000
| Closed | -$852K | – | 110 |
|
|
2024
Q1 | $852K | Sell |
300,000
-1,569,125
| -84% | -$4.46M | 0.01% | 99 |
|
|
2023
Q4 | $27.5M | Sell |
1,869,125
-819,748
| -30% | -$12.1M | 0.61% | 44 |
|
|
2023
Q3 | $49.2M | Sell |
2,688,873
-2,185,046
| -45% | -$40M | 1.64% | 18 |
|
|
2023
Q2 | $105M | Sell |
4,873,919
-1,160,725
| -19% | -$25M | 3.04% | 5 |
|
|
2023
Q1 | $177M | Sell |
6,034,644
-53,689
| -0.9% | -$1.58M | 5.23% | 3 |
|
|
2022
Q4 | $225M | Buy |
6,088,333
+616,300
| +11% | +$22.8M | 6.32% | 2 |
|
|
2022
Q3 | $154M | Buy |
5,472,033
+1,931,625
| +55% | +$54.4M | 4.47% | 5 |
|
|
2022
Q2 | $68.2M | Buy |
3,540,408
+2,066,301
| +140% | +$39.8M | 2.14% | 10 |
|
|
2022
Q1 | $18.9M | Buy |
+1,474,107
| New | +$18.9M | 0.38% | 61 |
|